Wayne State Awarded $2.28 Million to Study Use of Buprenorphine to Combat Relapse in Recovering Opioid Users
Wayne State University Division of ResearchA team led by Wayne State University School of Medicine researcher Mark Greenwald, Ph.D., will use a four-year, $2,279,723 competitively renewed grant from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health to explore whether the opioid addiction treatment medication buprenorphine can decrease the magnitude and/or duration of responses to stressors faced by recovering addicts. The results of the study could reveal a new therapeutic feature of the drug, possibly helping drug-abstinent individuals avoid relapse.